💨 Abstract

Acadia Pharmaceuticals reported a first-quarter profit of $19 million, or 11 cents per share, and revenue of $244.3 million, both exceeding Wall Street expectations. The company anticipates full-year revenue between $1.03 billion and $1.1 billion. However, despite the positive earnings report, Acadia’s shares have declined 19% year-to-date, trading at $14.81,

Courtesy: wtop.com

Summarized by Einstein Beta 🤖